🔍

GODREJAGRO - Godrej Agrovet

📊 NSE: GODREJAGRO 🏢 Food - Processing - Indian 📅 Last Updated: 12/13/2025 22:28

📢 Recent Corporate Announcements

Godrej Agrovet Clarifies Expansion News; Reports 33.9% Adjusted PAT Growth in Q3 FY26

🟡 NEUTRAL ⭐ 4/10

ROUTINE 📅 06 Mar 2026, 11:08 AM

Godrej Agrovet clarified to the exchanges that recent news regarding its Crop Protection expansion in North and East India is consistent with its existing disclosures and investor presentations. For Q3 FY26, the company reported an 11% YoY revenue growth to ₹2,718 crore and a 33.9% surge in adjusted PAT to ₹133 crore. Growth was primarily driven by the Vegetable Oil segment (revenue +27%) and robust volumes in Cattle Feed (+21%). However, the Dairy segment remains under pressure with EBITDA declining 38% due to high milk procurement costs.

Consolidated Revenue increased 11% YoY to ₹2,718 crore in Q3 FY26
Adjusted Profit After Tax (PAT) grew by 33.9% YoY to ₹133 crore
Vegetable Oil segment revenue rose 27% YoY driven by 16% growth in Fresh Fruit Bunch arrivals
Animal Feed volumes grew 12% YoY, with Cattle Feed specifically surging by 21%
Dairy segment EBITDA fell 38% YoY due to higher procurement prices and flat volumes

💡 Investors should focus on the company's ability to maintain margins in the Dairy segment and the successful ramp-up of new in-licensed products in the Crop Protection business. The strong performance in the Oil Palm and Feed businesses provides a solid foundation for the diversified agri-major.

Godrej Agrovet Receives Income Tax Notice for ₹41.36 Lakhs

🟡 NEUTRAL ⭐ 3/10

REGULATORY 📅 24 Feb 2026, 10:11 PM

Godrej Agrovet Limited has received a notice from the Income Tax Department demanding a payment of ₹41,36,010. The notice, issued under Section 226(3) of the Income Tax Act, 1961, pertains to late payment interest and late filing levies. The company's banker, HDFC Bank, was notified of this demand on February 23, 2026. Management has confirmed that this development will not have any material impact on the company's financial or operational performance.

Income Tax Department demands ₹41,36,010 for late payment interest and filing levies.
Notice issued under Section 226(3) of the Income Tax Act, 1961 to HDFC Bank Limited.
Company states there is no material impact on financial or operational activities.
Godrej Agrovet is in the process of filing a correction statement with the tax authorities.

💡 This is a minor regulatory matter with negligible financial impact; no action is required from investors.

Godrej Agrovet Q3 FY26: 11% Revenue Growth and 23% PBT Increase

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 11 Feb 2026, 01:42 PM

Godrej Agrovet reported a strong Q3 FY26 with consolidated revenue growing 11% YoY and PBT (before exceptional items) rising 23%. The performance was bolstered by a 27% revenue jump in the Vegetable Oil business and a 12% volume growth in Animal Feed. Astec LifeSciences showed a sharp recovery with 33% revenue growth and a return to positive EBITDA of INR 5 crores. Management indicated a strategic portfolio review is underway to prioritize high-growth segments, with updates expected by April 2026.

Consolidated revenue grew 11% YoY in Q3 FY26, while 9M FY26 PBT rose 17% to INR 482 crores.
Vegetable Oil segment revenue grew 27% YoY with a record oil extraction ratio (OER) of 21%.
Animal Feed volumes increased 12% YoY, led by a significant 21% growth in cattle feed.
Astec LifeSciences turned EBITDA positive at INR 5 crores compared to a loss in the previous year.
Branded salience in the Foods business reached 81%, driving a 51% YoY growth in segment EBITDA to INR 17 crores.

💡 Investors should maintain a positive outlook given the operational efficiencies and the turnaround in Astec LifeSciences. Key focus should remain on the upcoming strategic portfolio review in April 2026 which may unlock further value.

Godrej Agrovet Launches 'TAKAI' Insecticide for Rice Crops to Combat 40% Yield Loss

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 07 Feb 2026, 11:00 AM

Godrej Agrovet has launched 'TAKAI,' a new insecticide for rice crops powered by Cyclapryn™ technology from ISK Japan. The product specifically targets Stem Borer and Leaf Folder pests, which are responsible for yield losses of up to 40% and 30% respectively in Indian rice farming. With India producing 150.18 million tonnes of rice annually but maintaining low yields of 2.9 tonnes/hectare, this product addresses a significant productivity gap. The company is also pursuing label approvals to expand the product's use to six additional crops, including Maize, Soybean, and Sugarcane.

Launched 'TAKAI' insecticide targeting pests that cause 30-40% yield loss in rice crops.
Powered by advanced Cyclapryn™ technology through a strategic partnership with ISK Japan.
Addresses a massive domestic market where India produces 150.18 million tonnes of rice annually.
Expansion plans in progress for label approvals in Maize, Chilli, Cabbage, Soybean, Chickpea, and Sugarcane.
Recommended application of 160 ml dose provides long-lasting protection during critical growth stages.

💡 Investors should view this as a positive development for the Crop Protection segment, as it strengthens the portfolio with high-tech, high-impact solutions. Monitor the upcoming label approvals for other crops as they will be key drivers for volume growth in the medium term.

Godrej Agrovet Releases Audio Recording of February 2026 Investor Conference Call

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 04 Feb 2026, 06:19 PM

Godrej Agrovet Limited has informed the exchanges that the audio recording of its conference call with analysts and institutional investors, held on February 4, 2026, is now available. The call took place at 3:30 p.m. IST to discuss the company's performance and outlook. Investors can access the recording via the company's official website under the corporate announcements section. This is a standard regulatory filing following an earnings or operational update call.

Conference call conducted on February 4, 2026, at 3:30 p.m. IST
Audio recording link made available for public access on the company website
Compliance filing submitted to both BSE and NSE as per regulatory requirements
The call involved discussions with various institutional investors and market analysts

💡 Investors interested in management's detailed commentary on segment-wise performance should listen to the recording. No immediate portfolio action is required based on this procedural announcement.

Godrej Agrovet Q3 FY26: Profit Jumps 23% and Revenue Grows 11% on Strong Segment Performance

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 03 Feb 2026, 09:52 PM

Godrej Agrovet reported a robust Q3 FY26 with revenue growing 11% and profitability increasing by 23% year-on-year. The growth was primarily driven by the Vegetable Oil segment, which saw a 25% profit increase, and the Poultry business, where EBITDA surged by 51%. Astec LifeSciences showed a significant turnaround by returning to positive EBITDA, while the Animal Feed business maintained strong volume growth in the cattle feed category. However, the Dairy segment and Crop Protection faced headwinds from high procurement costs and unseasonal weather, respectively.

Consolidated profitability increased by 23% y-o-y with revenue growth of 11% in Q3 FY26.
Vegetable Oil segment profit grew 25% driven by 16% FFB growth and 30 bps improvement in Oil Extraction Ratio.
Poultry business EBITDA surged 51% y-o-y as branded product salience reached 81%.
Animal Feed cattle volumes grew 21% y-o-y, with EBIT per metric ton improving to Rs. 2,020.
Astec LifeSciences returned to positive EBITDA supported by higher volumes in enterprise and CDMO categories.

💡 Investors should focus on the strong turnaround in Astec LifeSciences and the sustained margin expansion in the core Vegetable Oil and Feed businesses. While Dairy remains a drag, the overall diversified portfolio is showing strong operational execution.

Godrej Agrovet Q3 FY26: Revenue Up 11%, Adjusted PAT Surges 33.9% Amid Strong Operational Growth

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 03 Feb 2026, 09:50 PM

Godrej Agrovet reported a strong Q3 FY26 with consolidated revenue growing 11% YoY to ₹2,718 crore, driven by robust performance in Vegetable Oil and Animal Feed segments. While reported PAT remained flat at ₹110 crore, adjusted PAT (excluding non-recurring items) grew significantly by 33.9% to ₹133 crore. The Animal Feed segment saw a 21% volume growth in cattle feed, and the Vegetable Oil business benefited from a 16% increase in Fresh Fruit Bunch arrivals. However, the Dairy segment faced headwinds due to higher procurement prices, leading to a 38% drop in EBITDA.

Consolidated Revenue grew 11% YoY to ₹2,718 crore, with EBITDA rising 13.6% to ₹260 crore
Adjusted PAT (excluding non-recurring items) increased by 33.9% YoY to ₹133 crore
Animal Feed segment recorded 12% volume growth, led by a 21% surge in cattle feed volumes
Vegetable Oil business EBIT grew 25% YoY, supported by 16% growth in FFB arrivals
Astec LifeSciences turned EBITDA positive at ₹5 crore compared to a loss of ₹4 crore in Q3 FY25

💡 Investors should note the strong margin expansion in the core Oil Palm and Animal Feed businesses, along with the turnaround in Astec LifeSciences. The stock remains a solid play on the Indian agricultural value chain, though dairy margin volatility warrants monitoring.

Godrej Agrovet Q3 Revenue Grows 11% to ₹2,718 Cr; Net Profit Flat at ₹110 Cr

🟡 NEUTRAL ⭐ 8/10

EARNINGS 📅 03 Feb 2026, 04:45 PM

Godrej Agrovet reported a steady 11% year-on-year growth in consolidated revenue, reaching ₹2,718.32 crore for Q3 FY26. However, consolidated net profit remained flat at ₹109.73 crore, largely due to a one-time exceptional charge of ₹30.44 crore related to the implementation of new Labour Codes. The company has significantly consolidated its portfolio, increasing its stake in Creamline Dairy to 99.78% and making Godrej Foods a wholly-owned subsidiary. Despite the exceptional hit, the underlying operational performance remains stable with a slight increase in basic EPS to ₹5.97.

Consolidated Revenue from Operations rose 11% YoY to ₹2,718.32 crore from ₹2,449.63 crore.
Consolidated Net Profit for the quarter stood at ₹109.73 crore, compared to ₹109.85 crore in the same period last year.
Recognized a one-time exceptional loss of ₹30.44 crore (consolidated) due to the statutory impact of new Labour Codes on gratuity and leave encashment.
Increased stake in Creamline Dairy Products Limited to 99.78% following a ₹708.58 crore acquisition.
Shareholding in Astec LifeSciences Limited increased to 67.03% from 64.75% after participating in a rights issue.

💡 Investors should view the flat profit growth as a temporary outcome of non-recurring exceptional items related to regulatory labor law changes. The long-term focus should be on the company's successful consolidation of its dairy and poultry subsidiaries, which may lead to better operational synergies.

Godrej Agrovet Q3 FY26: Revenue Grows 11% YoY to ₹2,718 Cr; PAT Flat at ₹110 Cr

🟡 NEUTRAL ⭐ 8/10

EARNINGS 📅 03 Feb 2026, 04:44 PM

Godrej Agrovet reported a steady 11% YoY growth in consolidated revenue, reaching ₹2,718.32 crore for Q3 FY26. Consolidated net profit remained nearly flat at ₹109.73 crore compared to ₹109.85 crore in the previous year, largely due to a one-time exceptional charge of ₹30.44 crore related to the implementation of new Labour Codes. The company has strengthened its portfolio by increasing its stake in Creamline Dairy to 99.78% and Astec LifeSciences to 67.03%. Operational performance remains resilient despite the statutory impact on the bottom line.

Consolidated Revenue from Operations increased 11% YoY to ₹2,718.32 crore in Q3 FY26.
Consolidated PAT stood at ₹109.73 crore, including a ₹30.44 crore exceptional item for new Labour Code provisions.
Nine-month consolidated revenue reached ₹7,900.03 crore, up from ₹7,249.13 crore YoY.
Company increased stake in Creamline Dairy Products Limited to 99.78% and Astec LifeSciences to 67.03%.
Standalone PAT for the quarter was ₹115.56 crore, down from ₹166.17 crore in the previous year's quarter.

💡 Investors should focus on the underlying revenue growth and the impact of increased ownership in subsidiaries, while treating the PAT stagnation as a result of a non-recurring statutory charge. Monitor the margin performance in the dairy and life sciences segments as the company consolidates these holdings.

Godrej Agrovet Clarifies No Undisclosed Information Amidst Trading Volume Spurt

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 03 Feb 2026, 10:49 AM

Godrej Agrovet Limited has responded to a clarification request from the National Stock Exchange regarding a significant increase in trading volume. The company stated that it is in full compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, and has disclosed all material events. Management confirmed there are no pending developments or price-sensitive information that require disclosure at this time. This response indicates that the recent volume surge is likely market-driven rather than based on undisclosed corporate actions.

NSE issued a surveillance inquiry (Ref. No. NSE/CM/Surveillance/16416) on February 2, 2026.
Company confirmed compliance with SEBI Listing Obligations and Disclosure Requirements (LODR) 2015.
Management stated no mandatory disclosures are pending under SEBI Prohibition of Insider Trading (PIT) Regulations.
The official response was filed on February 3, 2026, to address the recent spurt in trading volume.

💡 Investors should view the recent volume increase as market activity without immediate fundamental triggers. Continue to monitor the stock for any actual news or upcoming financial results.

Godrej Agrovet Schedules Q3 & 9MFY26 Earnings Conference Call for February 4, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 16 Jan 2026, 02:35 PM

Godrej Agrovet Limited has scheduled its earnings conference call for Wednesday, February 4, 2026, at 3:30 PM IST. The call will discuss the financial performance for the third quarter and nine months ended December 31, 2025 (3Q & 9MFY26). Senior leadership, including Chairman Nadir Godrej and CEO Sunil Kataria, will be present to provide insights and answer investor queries. The call is being hosted by Equirus Securities and will also feature management from subsidiary Astec LifeSciences.

Conference call scheduled for February 4, 2026, at 3:30 PM IST following 3Q & 9MFY26 results.
Management representation includes Chairman Nadir Godrej, CEO Sunil Kataria, and CFO S. Varadaraj.
Leadership from subsidiary Astec LifeSciences will also participate in the discussion.
Primary dial-in numbers for the session are +91 22 6280 1224 and +91 22 7115 8125.

💡 Investors should monitor the financial results release prior to the call and listen for management commentary on segment-wise margins and the outlook for the agri-input sector.

Godrej Agrovet Submits Q3 FY26 Compliance Certificate Under SEBI Regulation 74(5)

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 07 Jan 2026, 03:51 PM

Godrej Agrovet Limited has filed its quarterly compliance certificate for the period ending December 31, 2025. The document, issued by registrar KFIN Technologies Limited, confirms compliance with SEBI (Depositories and Participants) Regulations, 2018. The registrar specifically noted that no Demat or Remat requests were processed during this quarter. This filing is a routine regulatory requirement for listed companies in India to ensure shareholding record integrity.

Compliance certificate filed for the quarter ended December 31, 2025.
Issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
Registrar KFIN Technologies confirmed 0 Demat or Remat requests processed during the period.
Submission made to NSE and BSE on January 7, 2026.

💡 This is a routine regulatory filing with no impact on company fundamentals. No action is required from investors based on this announcement.

Godrej Agrovet to Close Trading Window from Jan 1, 2026 for Q3 FY26 Results

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 26 Dec 2025, 11:20 AM

Godrej Agrovet Limited has announced the closure of its trading window starting January 1, 2026, in compliance with SEBI insider trading regulations. This closure is ahead of the declaration of the company's unaudited financial results for the quarter and nine-month period ending December 31, 2025. The window will remain closed for all designated persons, including directors and officers, until 48 hours after the results are made public. This is a standard regulatory procedure for listed companies in India.

Trading window closure effective from Thursday, January 1, 2026.
Closure relates to the financial results for the quarter ending December 31, 2025.
Window will reopen 48 hours after the official declaration of financial results.
Restriction applies to all Officers, Designated Employees, Directors, and Auditors of the company.

💡 No action is required as this is a routine regulatory filing. Investors should look out for the upcoming announcement of the Q3 earnings date to assess financial performance.

Godrej Agrovet Subsidiary to Invest INR 150 Crore in New Telangana Dairy Facility

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 09 Dec 2025, 05:39 PM

Godrej Agrovet's material subsidiary, Creamline Dairy Products (Godrej Jersey), has signed an MoU with the Government of Telangana to establish a state-of-the-art dairy processing plant. The company will invest INR 150 crore in this 40-acre facility, which is expected to create over 300 direct jobs within three years. This investment is part of a larger INR 10,000 crore commitment by the Godrej Industries Group in the state. The move aims to capitalize on the double-digit growth in value-added dairy products and address rising consumer demand for protein-rich nutrition.

INR 150 crore investment for a new dairy processing facility on a 40-acre plot in Telangana.
Expected to generate over 300 direct employment opportunities over a three-year period.
Strategic focus on high-growth value-added dairy products to meet evolving nutritional needs.
Part of Godrej Industries Group's broader plan to invest over INR 10,000 crore in Telangana across multiple sectors.
Strengthens the 'Godrej Jersey' brand presence in Southern India, leveraging nearly three decades of expertise.

💡 Investors should view this as a positive growth driver for the dairy segment, which is shifting toward higher-margin value-added products. Monitor the execution timeline and the subsequent impact on the subsidiary's revenue contribution to the consolidated entity.

View All GODREJAGRO Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

In Q2 FY26, Vegetable Oil revenue grew by 41% YoY, while Animal Feed revenue remained flat despite 18% volume growth in cattle feed. Stand-alone Crop Protection revenue declined sharply by 30% YoY. Consolidated revenue for H1 FY26 reached INR 5,182 Cr, an 8% YoY increase.

Geographic Revenue Split

Not disclosed in available documents; however, the company faces competition from both domestic and external players in the agro-chemicals segment.

Profitability Margins

Consolidated Net Profit Margin improved to 4.3% in FY25 from 3.8% in FY24. Operating Profit Margin rose to 8.7% in FY25 from 7.3% in FY24. In Q2 FY26, Vegetable Oil margins expanded to 22.4% due to higher realizations and extraction ratios.

EBITDA Margin

Operating margins were 9.0% in FY25 compared to 7.6% in FY24. Astec LifeSciences reported gross margins of 44% in Q2 FY26, a 4-5 year high, and is working toward breaking even on EBITDA.

Capital Expenditure

The company has a planned capital expenditure outlay of approximately INR 250-270 Cr per annum over the near term to support growth and recent acquisitions.

Credit Rating & Borrowing

CRISIL reaffirmed a 'Crisil A1+' rating for the INR 1,500 Cr Commercial Paper programme. The company maintains strong financial flexibility as part of the Godrej Group, allowing it to raise debt at competitive rates.

⚙️ Operational Drivers

Raw Materials

Key raw materials include Fresh Fruit Bunches (FFB) for palm oil, and commodities for animal feed such as maize and soya. Crude Palm Oil (CPO) and Palm Kernel Oil (PKO) realizations are critical for the vegetable oil segment.

Capacity Expansion

Not disclosed in available documents; however, the company is investing in value-added businesses and has recently acquired the balance stakes in Creamline Dairy Products Limited and Godrej Foods Limited.

Raw Material Costs

Raw material costs are subject to high volatility; softening commodity prices in Q2 FY26 led to lower realizations in the animal feed segment despite volume growth. Vegetable oil margins benefited from higher oil extraction ratios.

Manufacturing Efficiency

Vegetable oil efficiency is measured by the oil extraction ratio, which improved in Q2 FY26. Astec LifeSciences is driving margins through process efficiencies and cost controls.

📈 Strategic Growth

Expected Growth Rate

14%

Growth Strategy

Growth is driven by diversification into high-margin segments like Vegetable Oil (41% growth) and CDMO (30-31% margins). The company is focusing on process efficiencies, cost initiatives, and investing in value-added businesses while maintaining a healthy bottom-line growth trajectory of 14% YTD in H1 FY26.

Products & Services

Cattle feed, poultry feed, aqua feed, Crude Palm Oil (CPO), Palm Kernel Oil (PKO), agrochemicals (enterprise and CDMO), dairy products, and processed poultry.

Brand Portfolio

Godrej, Astec LifeSciences, Creamline Dairy Products, Godrej Foods.

New Products/Services

Not disclosed in available documents; however, the company is focusing on expanding its CDMO segment and value-added dairy/poultry products.

Market Expansion

Expansion is targeted through the palm oil business and increasing the application opportunities for agrochemicals in the crop protection segment.

Strategic Alliances

Recent acquisition of balance stakes in subsidiaries Creamline Dairy Products Limited (CDPL) and Godrej Foods Limited (GFL).

🌍 External Factors

Industry Trends

The industry is shifting toward diversified agri-businesses. Godrej Agrovet is positioning itself by reducing concentration in animal feed (now 48% of revenue) and growing its presence in specialized segments like CDMO and palm oil.

Competitive Landscape

Intense competition exists in the agro-chemicals business from both domestic and international players.

Competitive Moat

The 'Godrej' brand provides a significant moat, offering strong financial flexibility and favorable access to capital markets. Diversification across multiple agri-segments acts as a durable advantage against cyclicality.

Macro Economic Sensitivity

The business is sensitive to global and domestic demand-supply conditions and government regulations affecting selling prices and input availability.

Geopolitical Risks

Exposure to external players in the agro-chemicals business and global commodity price fluctuations.

⚖️ Regulatory & Governance

Industry Regulations

Operations are subject to government regulations regarding agriculture, pollution norms, and import/export restrictions.

Taxation Policy Impact

The company's operations are influenced by changes in government regulations and tax laws.

Legal Contingencies

The company notes that important factors influencing operations include potential litigations, though specific case values are not disclosed in the provided text.